Notice Information
Notice Title
Valganciclovir & Caspofungin Generic Medicines
Notice Description
The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.
Lot Information
Lot 1
This framework agreement is for the supply of the following medicines to NHS Scotland, Valganciclovir 50mg/ml powder for oral solution, Valganciclovir 450mg tablets, Caspofungin 50mg and 70 mg powder for solution for infusion. Each product line was treated as an individual lot and has been awarded as a single supplier framework.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000471605
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR278757
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
33631100 - Antifungals for dermatological use
33651400 - Antivirals for systemic use
Notice Value(s)
- Tender Value
- £2,250,000 £1M-£10M
- Lots Value
- £2,250,000 £1M-£10M
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 31 Mar 20178 years ago
- Submission Deadline
- 10 Jan 2017Expired
- Future Notice Date
- Not specified
- Award Date
- 6 Mar 20178 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
- Contact Name
- Hazel Johnstone, Nadia Crockett
- Contact Email
- hazel.johnstone@nhs.net, nadia.crockett@nhs.net
- Contact Phone
- +44 1698794410, +44 1698794460
Buyer Location
- Locality
- LARKHALL
- Postcode
- ML9 2QX
- Post Town
- Motherwell
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV265034
Valganciclovir & Caspofungin Generic Medicines - The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR278757
Valganciclovir & Caspofungin Generic Medicines - The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000471605-2017-03-31T00:00:00Z",
"date": "2017-03-31T00:00:00Z",
"ocid": "ocds-r6ebe6-0000471605",
"initiationType": "tender",
"parties": [
{
"id": "org-19",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "National Procurement, 2 Swinhill Avenue",
"locality": "Larkhall",
"region": "UKM",
"postalCode": "ML9 2QX"
},
"contactPoint": {
"name": "Nadia Crockett",
"email": "nadia.crockett@nhs.net",
"telephone": "+44 1698794460",
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.htmlh"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-29",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Hazel Johnstone",
"email": "hazel.johnstone@nhs.net",
"telephone": "+44 1698794410",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"id": "org-29"
},
"tender": {
"id": "NP46517",
"title": "Valganciclovir & Caspofungin Generic Medicines",
"description": "The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
},
{
"id": "33651400",
"scheme": "CPV"
},
{
"id": "33631100",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "1"
}
],
"value": {
"amount": 2250000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"tenderPeriod": {
"endDate": "2017-01-10T12:00:00Z"
},
"awardPeriod": {
"startDate": "2017-01-10T12:00:00Z"
},
"documents": [
{
"id": "NOV265034",
"documentType": "contractNotice",
"title": "Valganciclovir & Caspofungin Generic Medicines",
"description": "The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV265034",
"format": "text/html"
},
{
"id": "APR278757",
"documentType": "awardNotice",
"title": "Valganciclovir & Caspofungin Generic Medicines",
"description": "The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR278757",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"description": "This framework agreement is for the supply of the following medicines to NHS Scotland, Valganciclovir 50mg/ml powder for oral solution, Valganciclovir 450mg tablets, Caspofungin 50mg and 70 mg powder for solution for infusion. Each product line was treated as an individual lot and has been awarded as a single supplier framework.",
"status": "complete",
"value": {
"amount": 2250000,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 360
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
}
}
],
"bidOpening": {
"date": "2017-01-10T12:00:00Z"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA Best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants and any sub-contractor(s) must possess a UKAS (or equivalent) accredited independent third party certificate of compliance with BS EN ISO 14001 (or equivalent) or a valid EMAS (or equivalent) certificate.",
"minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) Confirmation of the existence of certificates drawn up by independent bodies attesting the compliance with the required environmental management systems or standards should be included in the Qualification Envelope of the ITT under Environmental Management Standards"
}
]
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"techniques": {
"hasFrameworkAgreement": true,
"frameworkAgreement": {
"maximumParticipants": 1
}
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts(Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"hasRecurrence": false
},
"language": "EN",
"description": "The estimated value referred to in Sections II.1.7 and V.2.4 covers the initial twelve (12) months duration of the Framework Agreement and a twenty-four (24) months extension options. For further detail on the award of each individual product line please contact the Authority using the information supplied at the head of this notice. (SC Ref:488914)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000471605"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000471605"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP46517",
"relatedLots": [
"1"
]
}
],
"contracts": [
{
"id": "NP46517",
"awardID": "NP46517",
"status": "active",
"dateSigned": "2017-03-06T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2016/S 229-417085"
}
]
}